tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market

Fate Therapeutics (FATE) Income Statement

Compare
1,256 Followers

Fate Therapeutics Income Statement

Last quarter (Q3 2025), Fate Therapeutics's total revenue was $1.74M, a decrease of -6.40% from the same quarter last year. In Q3, Fate Therapeutics's net income was $-32.25M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 13.63M$ 63.53M$ 96.30M$ 55.85M$ 31.43M
Gross Profit
$ 13.63M$ -93.65M$ 82.54M$ 50.00M$ -94.19M
Operating Expenses
$ 223.91M$ 96.86M$ 390.93M$ 266.99M$ 33.90M
Depreciation and Amortization
$ 18.96M$ 18.28M$ 13.76M$ 5.85M$ 3.09M
EBITDA
$ -176.58M$ -172.23M$ -294.63M$ -211.14M$ -125.00M
Operating Income
$ -210.28M$ -190.51M$ -308.39M$ -216.99M$ -128.09M
Other Income/Expenses
$ 24.01M$ 29.58M$ 26.66M$ 4.84M$ -45.30M
Pretax Income
$ -186.26M$ -160.93M$ -281.72M$ -212.15M$ -173.39M
Net Income
$ -186.26M$ -160.93M$ -281.72M$ -212.15M$ -173.39M
Per Share Metrics
Basic EPS
$ -1.64$ -1.64$ -2.91$ -2.24$ -2.10
Diluted EPS
$ -1.64$ -1.64$ -2.91$ -2.24$ -2.10
Weighted Average Shares Outstanding
113.69M 98.41M 96.83M 94.75M 82.39M
Weighted Average Shares Outstanding (Diluted)
113.69M 98.41M 96.83M 94.75M 82.39M
Currency in USD

Fate Therapeutics Earnings and Revenue History